Non-lethal Clostridium sordellii bacteraemia in an immunocompromised patient with pleomorphic sarcoma

Alex K Bonnecaze1, Sarah Ellen Elza Stephens2, Peter John Miller3

  • 1Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.

BMJ Case Reports
|August 5, 2016
PubMed

Insights

Clostridium sordellii infections are rare but deadly, often mimicking toxic shock syndrome. Early treatment with antibiotics and supportive care can improve outcomes in critically ill patients.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Toxicology

Background:

  • Clostridium sordellii is a rare cause of human infection, associated with high mortality rates.
  • Infections are often linked to gynecological procedures, intravenous drug use, or trauma.
  • The bacterium produces toxins like TcsH and TcsL that disrupt cellular integrity.

Observation:

  • C. sordellii infections present similarly to toxic shock syndrome (TSS), characterized by hypotension, hemoconcentration, and leukocytosis.
  • A key differentiator from TSS is the infrequent presence of fever in C. sordellii infections.
  • We report a case of C. sordellii bacteremia and septic shock in an immunocompromised patient with sarcoma.

Findings:

  • The patient presented with critical illness due to C. sordellii infection.
  • Aggressive hemodynamic resuscitation, source control, and intravenous antibiotics were administered.
  • The patient demonstrated clinical improvement following treatment.

Implications:

  • This case highlights the importance of considering C. sordellii in severe infections, especially in immunocompromised individuals.
  • Prompt and aggressive management, including antibiotics and supportive care, is crucial for patient survival.
  • Further research into C. sordellii pathogenesis and optimal treatment strategies is warranted.

Related Concept Videos